Cushman & Wakefield PLC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
Cushman & Wakefield announced robust second quarter 2026 financial results, highlighted by significant leasing revenue growth and an increase in annual Adjusted EPS guidance.
NYSE
Cushman & Wakefield announced an amendment to its Credit Agreement, extending term loan maturities, reducing pricing, and partially redeeming senior notes.
NYSE
Cushman & Wakefield Ltd. announced amendments to its credit agreement, including an upsizing and maturity extension of its senior secured term loan facility, alongside a partial redemption of its 2028 Notes.
NYSE
Cushman & Wakefield has successfully redeemed $100 million of its 6.750% Senior Secured Notes due 2028.
NYSE
Cushman & Wakefield shareholders approved the 2026 Omnibus Share and Cash Incentive Plan at the annual meeting, replacing prior plans and authorizing new share awards.
NYSE
Cushman & Wakefield announced record first quarter revenue of $2.5 billion, driven by robust leasing and capital markets performance, though net loss widened due to one-time charges.
NYSE
Cushman & Wakefield U.S. Borrower, LLC will redeem $100 million of its 6.750% Senior Secured Notes due May 2028.
NYSE
Cushman & Wakefield Ltd. has updated its historical financial information and will no longer report certain non-GAAP measures starting January 1, 2026, to better align with industry peers.
NYSE
Cushman & Wakefield announced record fourth quarter and full year 2025 revenue, alongside a significant impairment loss on its Greystone JV investment, impacting net income.
NYSE
Cushman & Wakefield Ltd. disclosed its Value Creation Framework targets for fiscal years 2026-2028, projecting significant growth in key financial and operational metrics.
NYSE
Cushman & Wakefield Ltd. has completed its redomiciliation from England and Wales to Bermuda, with new shares now trading on the NYSE under the same symbol CWK.
NYSE
Cushman & Wakefield reported robust third-quarter 2025 financial results, driven by double-digit capital markets growth and significant debt reduction, leading to an upward revision of its full-year Adjusted EPS guidance.
NYSE
Cushman & Wakefield successfully amended its revolving credit facility, extending maturity to October 2030, reducing interest rates, and right-sizing commitments to $1.0 billion.
NYSE
Cushman & Wakefield shareholders overwhelmingly approved the company's redomiciliation from England and Wales to Bermuda, aiming to reduce administrative burdens and costs.
NYSE
Cushman & Wakefield successfully repriced its $840 million Term Loan, reducing the interest rate by 25 basis points.
NYSE
Cushman & Wakefield reported robust second-quarter 2025 financial results, driven by significant growth in capital markets and leasing revenue, alongside improved profitability and a substantial debt reduction.
NYSE
Cushman & Wakefield has successfully repriced its $948 million Term Loan due 2030, reducing the interest rate by 50 basis points to Term SOFR plus 2.75%, marking the lowest margin since its public listing.
NYSE
Cushman & Wakefield announced the retirement of long-serving Chairman Brett White, effective July 31, 2025, and the appointment of Stephen D. Plavin as the new Chairman, alongside two new independent directors, Susan Daimler and Timothy Wennes, as part of a strategic board refreshment.
NYSE
Cushman & Wakefield's shareholders approved the Third Amended & Restated 2018 Omnibus Management Share and Cash Incentive Plan at the annual general meeting on May 15, 2025.
NYSE
Cushman & Wakefield announced positive Q1 2025 financial results, featuring revenue growth, margin improvement, and strategic investments.
NYSE
Cushman & Wakefield plans to change its jurisdiction of incorporation from England and Wales to Bermuda to reduce administrative costs and better align with its U.S. shareholder base.
NYSE
Cushman & Wakefield announced a 35% increase in global Capital markets revenue for the fourth quarter of 2024 and overall improved financial performance for the year.
NYSE
Cushman & Wakefield has successfully repriced its $990 million term loan, reducing the interest rate by 25 basis points.
NYSE
Cushman & Wakefield saw a significant turnaround in Q3 2024, marked by strong global leasing revenue growth and substantial improvements in cash flow.
NYSE
Cushman & Wakefield has successfully repriced its 2030 term loan, reducing the interest rate by 50 basis points, and fully repaid its 2025 term loan.
NYSE
Cushman & Wakefield saw a 2% increase in leasing revenue in Q2 2024, alongside a strategic sale of a non-core business, despite an overall revenue decrease of 5%.
NYSE
Cushman & Wakefield has successfully repriced its $1 billion Term Loan, reducing the interest rate by 25 basis points and expects to save approximately $14 million annually.
NYSE
Jonathan Coslet resigned from Cushman & Wakefield's board, and TPG has waived its rights to appoint directors, leading to the termination of the shareholder agreement.
NYSE
Cushman & Wakefield has announced a secondary public offering of 26,513,041 ordinary shares by existing shareholders, with the company not receiving any proceeds from the sale.
NYSE
Cushman & Wakefield's shareholders approved amended share and cash incentive plans for management and non-employee directors, and elected directors at the 2024 annual general meeting.